Nandita Khera, Sikander Ailawadhi, Ruta Brazauskas, Jinalben Patel, Benjamin Jacobs, Celalettin Ustun, Karen Ballen, Muhammad Bilal Abid, Miguel A Díaz, A Samar Al-Homsi, Hasan Hashem, Sanghee Hong, Reinhold Munker, Raquel Schears, Hillard M Lazarus, Stefan O Ciurea, Sherif M Badawy, Bipin N Savani, Baldeep Wirk, Charles F LeMaistre, Neel S Bhatt, Amer Beitinjaneh, Mahmoud Aljurf, Akshay Sharma, Jan Cerny, Jennifer M Knight, Amar H Kelkar, Jean A Yared, Tamila Kindwall-Keller, Lena E Winestone, Amir Steinberg, Staci D Arnold, Sachiko Seo, Jaime M Preussler, Nasheed M Hossain, Warren B Fingrut, Vaibhav Agrawal, Shahrukh Hashmi, Leslie Elaine Lehmann, William A Wood, Hemalatha G Rangarajan, Wael Saber, Theresa Hahn
There has been an increase in volume as well as improvement in overall survival (OS) after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if these changes have impacted racial/ethnic minorities equally. In this observational study from Center for International Blood and Marrow Transplant Research of 79,904 autologous (auto) and 65,662 allogeneic (allo) HCTs, we examined the volume and rates of change of auto HCT and allo HCT over time and trends in OS in 4 racial/ethnic groups: Non-Hispanic Whites (NHWs), Non-Hispanic African Americans (NHAAs), Hispanics across five 2-year cohorts from 2009 to 2018...
April 25, 2024: Blood Advances